Emgality 120 mg, solution injectable en stylo prérempli

7680670260015 CH-67026 Lösung
Emgality 120 mg, solution injectable en stylo prérempli
Emgality 120 mg, solution injectable en stylo prérempli
Emgality 120 mg, solution injectable en stylo prérempli
1 / 3
google

Article details

Package size
1 x 1 ml
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/10/2025
Patient information leaflet
Français
02/10/2025
Patient information leaflet
Italien
02/10/2025
Summary of Product Characteristics
Allemand
13/03/2024
Summary of Product Characteristics
Français
13/03/2024
Summary of Product Characteristics
Italien
13/03/2024

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.5 MG Substance HBESI

Reimbursement information

Public price
CHF 452.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2019

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67026
Drug name
Emgality, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
N02CD02
Authorization status
Z
Dispensing category
B
First authorization
29/03/2019
Authorization expiration date
31/12/9999
IT Number
02.05.1.
Domain
Human medicine

Package details

Description (FR)
EMGALITY sol inj 120 mg/ml stylo prérempli 1 ml
Description (DE)
EMGALITY Inj Lös 120 mg/ml Fertigpen 1 ml
Market launch
29/03/2019
Narcotic (BTM)
No

Other package sizes (1)

None
2 x 1 ml INJ
GTIN: None
Not in V1